Abexxa Biologics logo

Abexxa Biologics, Inc.

Abexxa Biologics, is a research stage bio-pharmaceutical startup focused on discovering and developing breakthrough antibody-based drugs to its proprietary class of targets designed to revolutionize cancer treatments by providing highly effective targeted therapies. Abexxa research facility is located at biotech innovation hub, LabCentral.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.abexxa.com
Disease Focus
Development Stage
STOCK CODENon Listed
Address
Nanofab Building, 500 South Cooper Street, Suite 203, Arlington,76019
Texas
United States
Email
Contact Number
+1 817-901-9610

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/abexxa-biologics-inc-” connections=”true” suffix=””]

Pipeline

AbeXXa is looking to identify a new series of selective molecular targets for cancer from the many thousands of proteins found on the interior of a tumor cell.

In 2016, AbeXXa won the Boston Innovation Prize sponsored by Boehringer Ingelheim and has also received funding through the Boehringer Ingelheim Venture Fund.
Also, In Sep 2016, Abexxa Biologics raised $1.25 Mn in seed funding through Equity.